Discover

ALC
Alcon Inc.
70.63
400 x 66.20
400 x 70.80
bid
ask
+
3.20
4.75%
400 @ 06:12 PM
70.32 -0.31 (0.44%)
Ytd-10.38%
1y-7.55%
68.00
day range
70.68
62.02
52 week range
87.18
Open68.02Prev Close67.43Low68.00High70.68Mkt Cap34.14B
Vol2.21MAvg Vol1.77MEPS1.38P/E51.18Forward P/E17.82
Beta0.73Short Ratio10.44Inst. Own63.09%Dividend0.36Div Yield0.53
Ex Div Date05-06Earning11-1050-d Avg68.02200-d Avg72.251yr Est82.73
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-102026-090.89N/AN/AN/A
2026-08-102026-060.770.840.079.09%
2026-05-052026-030.80.850.056.25%
2026-02-242025-120.790.78-0.01-1.27%
2025-11-112025-090.770.790.022.60%
2025-08-192025-060.710.760.057.04%
Upgrade / Downgrade
DateFirmActionFromTo
2026-10-21NeedhamUpgradeBuyBuy
2026-10-12BTIGUpgradeBuyBuy
2026-10-07BarclaysUpgradeEqual-Weight
2026-09-22JefferiesUpgradeBuyBuy
2026-09-15NeedhamUpgradeBuyBuy
2026-08-12JP MorganUpgradeNeutralNeutral
Profile
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Vanguard Capital Management LLC14.75M1.04B2.95%
2026-06-29Bank Of New York Mellon Corporation13.06M922.41M2.61%
2026-06-29NORGES BANK10.98M775.39M2.20%
2026-06-29Invesco Ltd.10.38M733.27M2.08%
2026-06-29Aristotle Capital Management, LLC9.98M704.92M2.00%
2026-06-29AKO Capital LLP9.68M684.01M1.94%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-07-30VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund7.18M506.86M1.44%
2026-06-29VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund4.76M336.17M0.95%
2026-08-30iShares Trust-iShares Core MSCI EAFE ETF3.69M260.34M0.74%
2026-08-30ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund3.28M231.96M0.66%
2026-07-30VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund2.92M206.13M0.58%
2026-05-30MFS SERIES TRUST X-MFS International Intrinsic Value Fund2.51M177.28M0.50%
Dividend
DividendDate
0.35932026-05-06
0.232032026-05-05
0.33342025-05-14
0.33342025-05-13
0.26472024-05-14
0.235742023-05-10